Cerro Pacific Wealth Advisors’s AbbVie ABBV Stock Holding History

Cerro Pacific Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	5,299 +26	+0.5%	+$5.59K	0.3%	61
2026 Q1	$1.15M	Sell	5,273 -82	-2%	-$18.2K	0.3%	64
2025 Q4	$1.22M	Buy	5,355 +52	+1%	+$11.8K	0.33%	60
2025 Q3	$1.23M	Sell	5,303 -61	-1%	-$12.4K	0.34%	61
2025 Q2	$996K	Buy	5,364 +241	+5%	+$44.8K	0.28%	68
2025 Q1	$910K	Sell	5,123 -49	-0.9%	-$9.53K	0.3%	69
2024 Q4	$1.02M	Buy	5,172 +236	+5%	+$43.4K	0.34%	67
2024 Q3	$847K	Buy	4,936 +25	+0.5%	+$4.67K	0.32%	69
2024 Q2	$842K	Buy	+4,911	New	+$814K	0.32%	70
2023 Q1	$1.41M	Buy	8,828 +1,907	+28%	+$292K	0.78%	35
2022 Q4	$1.12M	Buy	6,921 +86	+1%	+$13.2K	0.59%	46
2022 Q3	$917K	Buy	6,835 +427	+7%	+$61.3K	0.56%	48
2022 Q2	$981K	Buy	6,408 +2,270	+55%	+$347K	0.61%	39
2022 Q1	$671K	Sell	4,138 -615	-13%	-$89.3K	0.41%	79
2021 Q4	$644K	Sell	4,753 -52	-1%	-$6.14K	0.41%	76
2021 Q3	$518K	Sell	4,805 -110	-2%	-$12.6K	0.37%	91
2021 Q2	$554K	Buy	+4,915	New	+$554K	0.41%	73
2020 Q4	$878K	Buy	+8,191	New	+$787K	0.52%	59

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cerro Pacific Wealth Advisors's ABBV Position: Q2 2026 in Review

Cerro Pacific Wealth Advisors increased its AbbVie (ABBV) stake by 0.49% in Q2 2026, buying an estimated $5.59K and bringing the position to 5,299 shares worth $1.33M. The position accounts for 0.3% of the portfolio, ranked #61.

Cerro Pacific Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.41M in Q1 2023. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cerro Pacific Wealth Advisors held 5,299 shares of AbbVie worth $1.33M as of Q2 2026.
Cerro Pacific Wealth Advisors bought 26 AbbVie shares in Q2 2026, an estimated $5.59K.
AbbVie made up 0.3% of Cerro Pacific Wealth Advisors's portfolio in Q2 2026, its #61 holding.
Cerro Pacific Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
Cerro Pacific Wealth Advisors's AbbVie position peaked at $1.41M in Q1 2023.
4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.